Needle Free Drug Delivery Market by Technology, Site of Delivery, Applications, Distribution Channel and Geography. Key Players are Inovio Pharmaceuticals, 3M Pharmaceuticals, Antares Pharma, Crossject, Becton Dickinson and Company, MedImmune, Optinose an

Precision Business Insights (PBI) in its report titled “Needle Free Drug Delivery Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the needle free drug delivery market revenue growth over forecast period.

The needle free drug delivery was accounted for US$ XX Mn in 2018 and anticipated to account for US$ XX Mn by 2025. Increased prevalence of chronic diseases such as hepatitis B, hepatitis C, AIDS etc. which drives the extensive use of injections and in turn helps in the needle free drug delivery market revenue growth. The growing necessity of self-administration and a significant growth of the geriatric population adding fuel for the growth of the needle free drug delivery market. The ease of administration and pain-free drug delivery and increasing focus on the portable delivery devices has boosted the market growth. However, the restricted use of the needle-free injection systems may hamper the growth of the needle free drug delivery market.

Needle free drug delivery market segmented on the basis of type, application and end user.

Insulin Delivery Segment Expected to Dominate the Needle Drug Delivery Market

Based on application needle free drug delivery is segmented into pain management, insulin delivery, vaccine delivery and others. Insulin delivery was the most prominent application segment in the needle-free drug delivery device market in 2017. The growth of the segment can be to rising incidence of diabetes and increasing shift towards unhealthy lifestyle habits.

Jet Injectors Will Dominate the Revenue Share.

Based on technology the needle drug delivery market is segmented into Jet Injectors, inhaler technology, novel needle free technologies, transdermal patch technology. Jet injectors accounted for the largest share in the market, due to benefits associated with them over other traditional drug transportation devices with needles. These benefits include faster drug delivery into bloodstream and insulin distribution over a larger area in lower layer of an individual's skin. Jet injectors are utilized for a wide array of applications owing to their merits such as rapid administration, improved dosing accuracy, faster response rates, and better diffusion into tissues, reduced pain, reduced sharp waste, and easy portability.

Read more Insights at https://www.precisionbusinessinsights.com/market-reports/needle-free-drug-delivery-market/

North America, Accounts for Major Revenue Needle Free Drug Delivery Market

Precision Business Insights (PBI), needle free drug delivery market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America accounted for major revenue share owing to increase in the prevalence of chronic disorders. The adoption of the modern treatments is anticipated to drive the growth of the free drug delivery market. The Asia Pacific is expected to grow faster rate over the forecast period owing to the growing prevalence of chronic diseases and favorable patient demographics.

Strategic Collaboration Play Vital Role in Needle Free Drug Delivery Market

Market strategies such as collaboration play an important role in the development of needle free drug delivery market. For instance, i n February 2017, PharmaJet and Genexine collaborate on DNA vaccine development and commercialization of DNA vaccines for human applications using the PharmaJet needle-free injection systems.

Download free Sample Report at https://bit.ly/2Hv2vcM

Key players in the needle free drug delivery market include Inovio Pharmaceuticals, Inc.(U.S), 3M Pharmaceuticals (U.S), Antares Pharma, Inc. (U.S), Crossject SA (France), Becton Dickinson and Company (U.S), MedImmune, Inc. (U.S), Optinose, Inc. (U.S), PharmaJet (U.S).

Detailed Segmentation

By Technology

o Jet Injectors
o Inhaler Technology
o Novel Needle Free Technologies
o Transdermal Patch Technology

By Site of Delivery

o Intradermal Injectors
o Intramuscular Injectors
o Subcutaneous Injectors

By Application

o Pain management
o Insulin delivery
o Vaccine delivery
o Others

Geography

o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Russia
 Spain
 Italy
 Rest of Europe
o Asia-Pacific
 China
 Japan
 India
 ASEAN
 Rest of Asia Pacific
o Latin America
 Brazil
 Mexico
 Argentina
 Chile
 Rest of Latin America
o Middle East and Africa
 South Africa
 Gulf Cooperation Council Countries(GCCC)
 Rest of MEA

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

This release was published on openPR.